Applied Therapeutics, Inc.
APLTDelisted Feb 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001697532
Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Applied Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 38 | 36 | −2 |
| Shares | 19.7M | 19.3M | −402.5K (−2.0%) |
| Value | $15.1M | $15.6M | +$569.6K (+3.8%) |
New holders (7)
Institutions that held Applied Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,382,621 | $1.93M | 0.35% |
| WealthTrust Axiom LLC | 43,000 | $34.9K | 0.01% |
| US Bancorp | 18,091 | $14.7K | 0.00% |
| Virtu Financial LLC | 14,497 | $12.0K | 0.00% |
| Essex Financial Services, Inc. | 10,000 | $8.11K | 0.00% |
| Barclays PLC | 11 | $9 | 0.00% |
| Simplex Trading, LLC | 136 | $0 | 0.00% |
Sold out (9)
Institutions that held Applied Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| OrbiMed Advisors LLC | 3,050,921 | $2.32M |
| Bank of Montreal | 323,100 | $355.4K |
| Artal Group S.A. | 400,000 | $304.0K |
| Pura Vida Investments, LLC | 101,654 | $77.3K |
| Ergoteles LLC | 36,524 | $27.8K |
| Susquehanna International Group, LLP | 21,931 | $16.7K |
| Jane Street Group, LLC | 17,707 | $13.5K |
| Two Sigma Securities, LLC | 10,933 | $8.31K |
| Citadel Advisors LLC | 374 | $284 |